Feraheme

Type: Product
Name: Feraheme
First reported 20 hours ago - Updated 20 hours ago - 1 reports

AMAG Up on Q3 Earnings Beat, Revenues Up

Shares of AMAG Pharmaceuticals, Inc. ( AMAG - Snapshot Report ) were up 2.1% immediately after the company reported better-than-expected third-quarter 2014 earnings. Third-quarter 2014 earnings of 6 cents per share were better than the Zacks Consensus ... [Published Zacks.com - 20 hours ago]
First reported Oct 30 2014 - Updated Oct 30 2014 - 2 reports

AMAG Pharmaceuticals, Inc. Reports Financial Results For Third Quarter And Nine Months Ended September 30, 2014

20% Growth Results in Record U.S. Feraheme SalesLumara Health Acquisition on Track to Close in Fourth QuarterConference call scheduled for 8:00 a.m. EDT todayWALTHAM, Mass., Oct. 30, 2014 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq: AMAG ), ... [Published BioSpace - Oct 30 2014]
First reported Oct 28 2014 - Updated Oct 28 2014 - 1 reports

AMAG Pharmaceuticals (AMAG) Set to Announce Earnings on Thursday

AMAG Pharmaceuticals (NASDAQ:AMAG) is scheduled to post its Q314 quarterly earnings results on Thursday, October 30th. Analysts expect AMAG Pharmaceuticals to post earnings of ($0.08) per share and revenue of $26.30 million for the quarter. Individual ... [Published American Banking News - Oct 28 2014]
First reported Oct 06 2014 - Updated Oct 06 2014 - 1 reports

East Coast Biotech Roundup: Intarcia, Atlas, Visterra, & More

The oft-trodden path for a startup biotech is to aim for either a buyout or an IPO—or at minimum, a partnership with a big pharmaceutical company—before dealing with the hefty price tag of a Phase 3 study. One local biotech, however, took on the risk ... [Published Xconomy - Oct 06 2014]
First reported Sep 30 2014 - Updated Sep 30 2014 - 1 reports

AMAG Up on Roughly $1B deal with Lumara to Widen Portfolio

Shares of AMAG Pharmaceuticals, Inc. ( AMAG - Snapshot Report ) soared 28.2% after it announced that it will be acquiring privately held Lumara Health Inc. for approximately $1 billion in order to diversify its portfolio. The transaction, approved by ... [Published Zacks.com - Sep 30 2014]
First reported Sep 30 2014 - Updated Sep 30 2014 - 1 reports

Amag Pharmaceuticals to buy Lumara Health for $675m

Amag Pharmaceuticals has signed an agreement to acquire a privately held maternal health pharmaceutical company, Lumara Health, for $675m.The deal also includes an additional contingent consideration of up to $350m based on achievement of certain sales ... [Published Pharmaceutical Technology - Sep 30 2014]
First reported Sep 29 2014 - Updated Sep 30 2014 - 9 reports

Amag buys into maternal health business

Will acquire female health specialist Lumara HealthAmag Pharmaceuticals has agreed to pay $675m-plus to buy female health specialist Lumara Health in a deal that will see the latter firm broken up.The transaction will also see the remainder of Lumara's ... [Published PMLive - Sep 30 2014]
First reported Jun 09 2014 - Updated Jun 09 2014 - 1 reports

AMAG Pharma gets patent term extension for ferumoxytol injection in US

AMAG Pharmaceuticals has announced that the US Patent and Trademark Office (USPTO) has issued a US patent term extension certificate extending the term of US Patent No. 6,599,498 by 1,209 days.With this extension the '498 patent will now expire 30 June ... [Published Pharmaceutical Business Review - Jun 09 2014]

Quotes

...further business diversification and create value for our shareholders," said Frank Thomas, executive vice president and chief operating officer. "Plans for integrating these two businesses are well underway, and we believe they will allow us to efficiently and quickly capture value following the close of the acquisition. We also feel confident that we are on track to complete the loan syndication process and close the transaction by the end of the year."
"We believe the Lumara Health transaction will facilitate future product acquisitions in an attractive new therapeutic area and is an excellent strategic fit with our Feraheme market expansion plans."
"If every eligible patient were treated with Makena, this represents greater than a $1 billion market potential" Heiden said
"This is a truly transformative transaction that will propel AMAG into a profitable, high-growth multi-product specialty pharmaceutical company" remarked CEO William Heiden...

More Content

All (25) | News (24) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (1)
sort by: Date | Relevance
AMAG Up on Q3 Earnings Beat, Revenues Up [Published Zacks.com - 20 hours ago]
AMAG Pharmaceuticals, Inc. Reports Financial Re... [Published BioSpace - Oct 30 2014]
AMAG Pharmaceuticals Reports Financial Results ... [Published Virtual Strategy Magazine - Oct 30 2014]
AMAG Pharmaceuticals (AMAG) Set to Announce Ear... [Published American Banking News - Oct 28 2014]
East Coast Biotech Roundup: Intarcia, Atlas, Vi... [Published Xconomy - Oct 06 2014]
AMAG Up on Roughly $1B deal with Lumara to Wide... [Published Zacks.com - Sep 30 2014]
Amag Pharmaceuticals to buy Lumara Health for $... [Published Pharmaceutical Technology - Sep 30 2014]
Amag buys into maternal health business [Published PMLive - Sep 30 2014]
Amag $1 billion deal to buy preterm birth drug ... [Published Pharma Times - Sep 30 2014]
Amag Pharma enters women health business with $... [Published Yahoo! News - Sep 29 2014]
AMAG Pharmaceuticals, Inc. Shells Out $675 Mill... [Published BioSpace - Sep 29 2014]
AMAG Pharmaceuticals to buy Lumara's maternal h... [Published FirstWord Pharma - Sep 29 2014]
Troubled AMAG snaps up fresh-from-bankruptcy Lu... [Published FiercePharma - Sep 29 2014]
Amag agrees to buy Lumara’s maternal health bus... [Published Boston Globe - Sep 29 2014]
Lumara Health™ to be Acquired in Two Separate T... [Published Stockwatch - Sep 29 2014]
AMAG Pharmaceuticals to Acquire Lumara Health M... [Published Virtual Strategy Magazine - Sep 29 2014]
AMAG Pharmaceuticals to Acquire Lumara Health -3- [Published Scottrade - Sep 29 2014]
AMAG Pharmaceuticals to Acquire Lumara Health M... [Published Scottrade - Sep 29 2014]
AMAG Pharmaceuticals to Acquire Lumara Health -2- [Published Scottrade - Sep 29 2014]
AMAG Pharmaceuticals Appoints Judith Johnson, M... [Published GlobeNewswire: Acquisitions News - Sep 16 2014]
AMAG Pharma gets patent term extension for feru... [Published Pharmaceutical Business Review - Jun 09 2014]
AMAG Announces First Quarter 2014 Financial Res... [Published GlobeNewswire - Apr 24 2014]
AMAG Pharmaceuticals Announces Proposed Offerin... [Published GlobeNewswire - Feb 10 2014]
AMAG Pharma's ferumoxytol gets new US patent [Published PharmaBiz - Feb 04 2014]
AMAG Pharmaceuticals gets new US patent for fer... [Published Pharmaceutical Business Review - Feb 03 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Press Releases

sort by: Date | Relevance
AMAG Pharmaceuticals Appoints Judith Johnson, M... [Published GlobeNewswire: Acquisitions News - Sep 16 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.